Earning Analysis
Welcome to our in-depth analysis of cbdMD Inc(YCBD) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of cbdMD Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q3 | 2025-08-14 | After Hours | - | - | - | 5.30M | 4.61M | -13.13 | -10.98 | -22.31 |
| FY2025Q2 | 2025-05-15 | After Hours | - | - | - | 5.14M | 4.75M | -7.63 | -4.04 | -8.23 |
| FY2025Q1 | 2025-02-13 | After Hours | - | - | - | 5.19M | 5.11M | -1.42 | -15.09 | -21.05 |
| FY2024Q3 | 2024-08-14 | After Hours | - | -0.15 | - | 4.93M | 5.17M | +5.03 | +1.65 | +13.40 |
| FY2024Q2 | 2024-05-15 | - | - | -1.35 | - | 5.40M | 4.38M | -19.00 | -0.56 | -1.55 |
YCBD Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, cbdMD Inc reported performance for FY2025Q3, announced on 2025-08-14. The company achieved an EPS of , compared to analyst estimates of by % . Revenue for the quarter reached 4.61M compared to expectations of 5.30M by -13.13% .
The stock price reacted with a -10.98% one-day change and a -22.31% five-day change following the earnings release. These movements reflect market reaction in cbdMD Inc growth trajectory and strategic initiatives.
YCBD Earnings Forecast
Looking ahead, cbdMD Inc(YCBD) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 4.70M and an EPS of -0.07.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming Q4 2025, revenue estimates have been adjusted No Change by 0% . These revisions correlate with a -16.30% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in cbdMD Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between YCBD's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Revenue Estimates for Q4 2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-16.30%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:19.17M
--
EPS Estimate-Annual FY 2025:-1.08
—
Stock Price0.61
YCBD Revenue and EPS Performance: A Historical Perspective
cbdMD Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-08-14,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 4.61M (Actual) vs. 5.30M (Estimate) (-13.13%)
Price Reaction: -10.98%(1-Day), -22.31%(5-Day)
FY2025Q2 (2025-05-15,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 4.75M (Actual) vs. 5.14M (Estimate) (-7.63%)
Price Reaction: -4.04%(1-Day), -8.23%(5-Day)
FY2025Q1 (2025-02-13,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 5.11M (Actual) vs. 5.19M (Estimate) (-1.42%)
Price Reaction: -15.09%(1-Day), -21.05%(5-Day)
Earnings Reaction
The chart below shows how YCBD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, YCBD sees a +24.95% change in stock price 10 days leading up to the earnings, and a -6.92% change 10 days following the report. On the earnings day itself, the stock moves by -0.85%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed -10.98% on the day following the earnings release and then changed by -8.77% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
cbdMD Inc (YCBD) Q2 2025 Earnings Call Summary
Neutral
2025-05-17
The earnings call reveals mixed signals: a slight revenue increase and improved cost structure are positive, but regulatory challenges and liquidity risks temper optimism. The new product expansion and capital structure improvements could yield future benefits, yet current financial constraints and market competition pose challenges. Analysts' cautious sentiment in the Q&A further supports a neutral outlook.
cbdMD Inc (YCBD) Q2 2025 Earnings Call Summary
Neutral
2025-05-15
The earnings call reveals mixed signals: revenue growth, debt-free status, and improved profitability are positive. However, the flat e-commerce sales, competitive pressures, and financial risks temper this optimism. The Q&A section highlights potential growth from Herbal Oasis, but regulatory issues and unclear guidance on financial metrics raise concerns. The conversion of preferred stock aids capital structure, but the impact of accrued dividends and liquidity remains uncertain. Overall, the sentiment is neutral, with no strong catalysts to drive significant stock price movement in the short term.
cbdMD Inc (YCBD) Q2 2025 Earnings Call Summary
Neutral
2025-05-15
The earnings call presents a mixed picture. Financial performance shows improvement with a revenue increase and reduced losses, but there are concerns like competitive pressures, supply chain issues, and a working capital deficit. The Q&A section reveals optimism about future growth, particularly with Herbal Oasis, and improved capital structure. However, management's vague responses on specific metrics and the working capital deficit pose risks. Considering these factors, the stock price is likely to remain neutral in the short term.
cbdMD Inc (YCBD) Q1 2025 Earnings Call Summary
Negative
2025-02-15
The earnings report showed mixed signals: a revenue increase and improved net income, but a significant EPS miss and capital restructuring challenges. The Q&A indicated tighter margins and slow wholesale distribution, with management's unclear responses on key metrics. Regulatory compliance issues and shareholder concerns add to the negative sentiment. While there were some positive aspects, such as debt reduction and a slight net income, the overall financial instability and market challenges suggest a negative stock price movement in the near term.
People Also Watch
FAQ
What were the key highlights of YCBD’s latest earnings report for FY2025Q3?
How did YCBD’s stock price react after the FY2025Q3 earnings release?
What are the revenue and EPS estimates for YCBD for 2025/Q4?
How does YCBD’s stock price correlate with earnings forecast revisions?
What should investors expect from YCBD’s next earnings report?